The Bacterial Vaccines Network (BactiVac) recently announced it had secured £1 million of funding to accelerate the development of bacterial vaccines and combat the threat of antimicrobial resistance (AMR).
The funding was awarded by Wellcome and will enhance the impact of the BactiVac Network over the next four years.
In a July 2022 report, the World Health Organization identified innovative AMR vaccines could reduce the incidence of bacterial infections and the widespread use and misuse of antibiotics.
Read More
